Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.
Financial Statements
- Click here to download Becton Dickinson & Co.'s Income Statement
- Click here to download Becton Dickinson & Co.'s Balance Sheet
- Click here to download Becton Dickinson & Co.'s Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Thomas Polen
Key Statistics
- Stock Price: $258.53
- Dividend Yield: 1.4000000000000001%
- Market Capitalization: $75,001,769,636
- Shares Outstanding: 290,108,574
- Number of Employees: 77,000
- Trailing 12-Month EPS: $5.52
- Trailing 12-Month DPS: $3.62
- Payout Ratio: 65.60000000000001%
Important Dates
- Next Earnings Date: 2023-11-09
- Next Ex-Dividend Date: 2023-09-07
Price Trends
- Current Stock Price: $258.53
- 52-week high: $286.34
- 52-week low: $212.77
- 200-day moving average: $258.88
- 50-day moving average: $270.36
Performance
- 1-Month Price Return: -7.8%
- 3-Month Price Return: -0.4%
- 6-Month Price Return: 7.2%
- 1-Year Price Return: 16.0%
- 2-Year Price Return: 8.2%
- 5-Year Price Return: 8.6%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast